Related Articles
Treatment time to the end of thoracic radiotherapy has more predictive power for survival than radiation dose intensity in patients with limited‑stage small‑cell lung cancer receiving concurrent chemoradiation of more than 45 Gy
A meta‑analysis of randomized controlled trials comparing early and late concurrent thoracic radiotherapy with etoposide and cisplatin/carboplatin chemotherapy for limited‑disease small‑cell lung cancer
Meta-analysis of the role of bevacizumab in extensive stage small cell lung cancer
Randomized controlled trial of lobaplatin plus etoposide vs. cisplatin plus etoposide as first‑line therapy in patients with extensive‑stage small cell lung cancer
Long‑term survival in a patient with extensive‑stage small cell lung cancer treated with multiple courses of salvage stereotactic radiation after whole brain radiotherapy: A case report